Covidien plc Announces Reporting Changes And Revised Revenue Guidance

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE:COV) today provided further details regarding its previously disclosed realignment of reportable segments and announced additional changes in its revenue reporting format. These changes are designed to further align with the company’s recent reorganization and provide additional transparency of financial performance.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC